Hypoxia inducible factor 1 (HIF-1) is a key player in cancer progression and an attractive target for cancer therapy. Several small molecule inhibitors of HIF-1a also induce a DNA damage response. However, whether or not DNA damage is required for or associated with the inhibition of HIF-1a protein accumulation is poorly understood. In this report we investigated the effects of distinct DNA damaging conditions on the hypoxic induction of HIF-1a protein in cancer cell lines. We demonstrate that in addition to topotecan (TPT), a known inhibitor of HIF-1a, UVC, but not other DNA damaging agents (cisplatin, ionizing radiation and doxorubicin), inhibited HIF-1a protein accumulation in a dose-dependent, p53-independent fashion. Low doses UVC decreased HIF-1a translation without affecting global protein synthesis. Inhibition of HIF-1a by UVC required ongoing RNA transcription, but not DNA replication. Moreover, a functional ATR was required for the activation of DNA damage-dependent responses by both UVC and TPT, but was dispensable for the inhibition of HIF-1a protein.
Introduction
Hypoxia is frequently found in solid tumors where it is associated with resistance to chemotherapy and radiotherapy, increased metastasis and poor prognosis (Brown and Giaccia, 1998; Harris, 2002) . Hypoxia Inducible Factor 1 (HIF-1) is a master regulator of the transcriptional response of mammalian cells to hypoxia and it regulates genes whose products are involved in angiogenesis, glucose metabolism, cell survival, invasion and metastasis (Semenza, 2006) . Over the last few years, HIF-1 has become an attractive target for therapy and an increasing number of inhibitors, which act at different levels of HIF-1 regulation, are being continuously discovered (Rapisarda et al., 2004a; Melillo, 2006; Semenza, 2006) .
A striking finding of a cell-based high throughput screen of the NCI open synthetic repository to identify HIF-1 inhibitors was that a large number of active compounds were also able to cause DNA damage, which raised the possibility that DNA damage-dependent signaling might be required for or associated with inhibition of HIF-1a protein. A prototype HIF-1 inhibitor with these characteristics is topotecan (TPT), a topoisomerase I inhibitor, which potently inhibits HIF-1a protein accumulation in a topoisomerase Idependent proteasome-independent fashion (Rapisarda et al., 2004b) . In an attempt to further investigate the potential association between DNA damage and HIF-1a inhibition, we have tested a number of conditions that cause DNA damage by different mechanisms, including cisplatin, doxorubicin, ionizing radiations (IR) and UVC irradiation. Interestingly, we found that UVC, but not cisplatin, IR or doxorubicin, inhibits hypoxic induction of HIF-1a protein accumulation in a p53-independent fashion. UVC inhibits HIF-1a protein translation, at doses that do not affect global protein synthesis. Inhibition of HIF-1a protein accumulation by UVC required ongoing RNA transcription, but not DNA replication, suggesting that DNA replicationdependent DNA damage is not important for the inhibition of HIF-1. Finally, neither ATM/ATR-dependent signaling pathways nor topoisomerase I expression were required for the inhibition of HIF-1a by UVC, further suggesting that DNA damage does not play a role in the inhibition of HIF-1a by UVC.
In conclusion, our results demonstrate that DNA damage is neither associated with nor required for HIF1a inhibition and they provide evidence of a novel signaling pathway mediated by UVC that inhibits HIF-1a translation in a topoisomerase I-independent fashion.
Results

UVC, but not cisplatin, IR or doxorubicin, inhibits hypoxia induced HIF-1a protein accumulation
To assess the ability of different DNA damaging agents to inhibit HIF-1a protein accumulation, U251 cells were cultured under normoxic or hypoxic conditions for 8 h in the presence or absence of TPT (0.5 mM), cisplatin (3 and 30 mM), doxorubicin (10 and 30 mM) or after being irradiated with UVC (20 and 200 J/m 2 ) or with IR (5 and 10 Gy). As shown in Figure 1a, To assess whether an intact p53 pathway has a role in the inhibition of HIF-1a, we performed experiments in HCT116 (p53 wild type). Cells were cultured under normoxic or hypoxic conditions for 8 h in the presence or absence of TPT (0.5 mM), cisplatin (3 and 30 mM), doxorubicin (10 and 30 mM) or after being irradiated with UVC (20 and 200 J/m 2 ) or with IR (5 and 10 Gy). As shown in Figure 1b , UVC and TPT, but not cisplatin, doxorubicin and IR, inhibited HIF-1a protein accumulation under hypoxic conditions, suggesting that an intact p53 pathway does not alter the ability of DNA damaging signals to affect HIF1a expression. On the contrary, levels of phosphorylated or total p53 and p21 expression were increased by TPT, UVC, IR and doxorubicin, consistent with the activation of DNA damage responses.
Taken together these data indicate that although all the agents used can induce DNA damage responses, only TPT and UVC are able to inhibit HIF-1a accumulation under hypoxia independently of a functional p53.
The unexpected finding that UVC inhibits HIF-1a protein accumulation, prompted us to further investigate the mechanism of action of HIF-1a inhibition. To determine the effective dose of UVC irradiation required to inhibit HIF-1a accumulation by 50% (ED50), U251 cells were irradiated with UVC (1-20 J/m 2 ) and then cultured under hypoxic conditions for 24 h. As shown in Figure 1c , UVC irradiation inhibited hypoxic induction of HIF-1a protein accumulation in a dose-dependent manner with an ED50 of about 5 J/m 2 . In addition, UVC (20 J/m 2 ) inhibited HIF-1a protein accumulation by 50% as early as 4 h after incubation under hypoxia (Figure 1d ).
These data demonstrate that UVC inhibits HIF-1a protein accumulation induced by hypoxia in a dose-and time-dependent fashion.
UVC irradiation inhibits HIF-1a protein translation at doses that do not affect global protein synthesis To evaluate whether UVC decreased hypoxic induction of HIF-1a protein accumulation by inhibiting its transcription, U251 cells were irradiated with UVC (20-200 J/m 2 ) and then cultured under normoxia or hypoxia for 24 h before assessing the expression of HIF1a and VEGF mRNA. HIF-1a mRNA accumulation was unchanged in U251 cells irradiated with 20 or 200 J/ m 2 UVC under both normoxia (data not shown) and hypoxia ( Figure 2a) . On the contrary, UVC significantly inhibited hypoxic induction of VEGF mRNA expression (8-fold compared to untreated control) by 50 and 90% at 20 and 200 J/m 2 UVC, respectively. These results demonstrate that UVC did not affect HIF-1a mRNA expression up to 24 h following irradiation, ruling out its involvement in the inhibition of HIF-1a protein accumulation, yet effectively inhibited the expression of VEGF, a classic HIF-1-target gene.
HIF-1a accumulation under low oxygen conditions is due to the inhibition of its degradation through the proteasome (Ivan et al., 2001; Jaakkola et al., 2001) . To test whether a functional proteasome was required for the inhibition of HIF-1a protein accumulation by UVC, U251 cells were irradiated with UVC (20-200 J/m 2 ), in the absence or presence of the proteasome inhibitor MG132 (20 mM), and then incubated under normoxic conditions for 8 h. As shown in Figure 2b , inhibition of the proteasome induced substantial accumulation of HIF-1a under normoxic condition. UVC completely inhibited HIF-1a protein accumulation induced by proteasome inhibition, indicating that UVC does not affect proteasome-dependent degradation of HIF-1a. These results lead us to test whether UVC affected HIF1a protein synthesis. UVC irradiated U251 cells (20 J/ m 2 ) were cultured under normoxic conditions in medium depleted of methionine and cysteine for 4 h.
35 S-labeledmethionine and cysteine were then added to the medium and the levels of HIF-1a protein were tested after 30, 60 and 120 min. As shown in Figure 2c , newly synthesized HIF-1a was detectable in untreated cells 60 min after the addition of the 35 S-labeled-methionine and cysteine, and further accumulated after 120 min. In contrast, cells irradiated with UVC (20 J/m 2 ) showed a delayed accumulation of HIF-1a, which was barely detectable after 120 min of incubation, suggesting that UVC inhibits HIF-1a protein translation without affecting its mRNA expression or proteasome degradation.
To assess whether the doses of UVC used under our experimental conditions were significantly inhibiting global protein synthesis, U251 cells were irradiated with UVC (20-200 J/m 2 ) or treated with cyclohexamide (CHX 40 mg/ml) for 4 h, in the absence of methionine and cysteine. De-novo protein synthesis was assessed by measuring total 35 S incorporation in TCA precipitated cell lysates following one hour of incubation with UVC might affect translation by inducing the phosphorylation of eIF2a (therefore inhibiting translation) (Wu et al., 2002; Jiang and Wek, 2005) or by decreasing the levels of eIF4E and eIF4A proteins, at least in part through the activity of the RNA-binding protein TIAR (Mazan-Mamczarz et al., 2006) . To assess whether, under our experimental conditions, UVC ) and then cultured under normoxic or hypoxic conditions for 8 h. Cells were also cultured in the presence or absence of TPT, which also inhibits HIF-1a protein translation (Rapisarda et al., 2004b) . As shown in Figure Ongoing RNA transcription, but not DNA replication, is required for the inhibition of HIF-1a by UVC UVC irradiation induces DNA damage through the formation of cyclobutane pyrimidine dimers (CPDs) and (6-4) photoproducts ((6-4)PPs) (Pfeifer et al., 2005) . To test whether DNA replication-mediated DNA damage was involved in the inhibition of HIF-1a by UVC, we used aphidicolin, a compound known to inhibit DNA replication therefore preventing the formation of DNA double strand breaks. U251 cells were irradiated with UVC (20 J/m 2 ) in the presence or absence of aphidicolin (5 mg/ml), and then cultured under normoxic or hypoxic conditions for 8 h. As shown in Figure 3a , aphidicolin treatment did not affect the induction of HIF-1a by hypoxia and did not prevent the inhibition of HIF-1a protein accumulation by UVC.
CPDs and (6-4)PPs formation on the transcribed strand of DNA, following UVC irradiation, halts the RNA transcription machinery (Tornaletti, 2005) . To assess whether RNA transcription was required for the inhibition of HIF-1a by UVC, U251 cells were pretreated with inhibitors of RNA transcription, such as actinomycin D, flavopiridol, and DRB, before UVC irradiation and analysis of hypoxic induction of HIF-1a accumulation. As shown in Figure 3b , actinomycin D treatment did not affect HIF-1a levels induced by hypoxia, but completely blocked the ability of low doses UVC (20 J/m 2 ) to inhibit HIF-1a protein accumulation. Consistent with these results, DRB and Flavopiridol, which block RNA transcription by mechanisms of action different from actinomycin D, also prevented UVC at 20 J/m 2 from inhibiting hypoxic induction of HIF-1a protein accumulation (data not shown). In contrast, inhibition of HIF-1a protein by high doses of UVC was not reverted by addition of actinomycin D (Figure 3b ) or flavopiridol and DRB (data not shown), further suggesting distinct mechanisms of HIF-1a inhibition between low and high doses of UVC.
Data presented to this point are consistent with a requirement for ongoing transcription, but not DNA replication, for the inhibition of HIF-1a by UVC irradiation. These results are remarkably similar to the mechanism of action by which TPT, a camptothecin analog and topoisomerase I poison, inhibits HIF-1a protein accumulation (Rapisarda et al., 2004b) . Both camptothecin analogs and UVC irradiation induce the stalling of RNA Pol II during RNA elongation, RNA Pol II hyper-phosphorylation (RNA Pol IIo) and degradation by a proteasome-dependent pathway (Bregman et al., 1996; Desai et al., 2003) . To test whether changes in RNA Pol II phosphorylation were associated with the inhibition of HIF-1a exerted by UVC and TPT, U251 cells were treated for 8 h under normoxia (data not shown) or hypoxia in the presence or absence of TPT (0.5 and 25 mM), cisplatin (3-30 mM), Actinomycin D (5 mg ml), Flavopiridol (0.5 mM) or after UVC irradiation (20-200 J/m 2 ) and the levels of total and phosphorylated RNA Pol II (Ser 5 ) were examined. As shown in Figure 3c , in U251 cells cultured under hypoxia the presence of both hyper-phosphorylated (RNA Pol IIo) DNA damage-independent inhibition of HIF-1a by UVC A Rapisarda and G Melillo and hypo-phosphorylated (RNA Pol IIa) forms were detectable, while in cells treated with UVC at 200 J/m 2 a marked decreased of total RNA Pol II expression was observed. Actinomycin D increased RNA Pol IIo and flavopiridol increased the RNA Pol IIa form (data not shown), as reported previously (Dubois et al., 1994; Sims et al., 2004) . TPT (0.5-25 mM), UVC (20 J/m 2 ) and cisplatin, induced a progressive shift in RNA Pol II toward its hyper-phosphorylated form, which was associated with an increase in Ser 5 phosphorylation.
In conclusion, these data suggest that changes in the phosphorylation status of RNA Pol II parallel the perturbation of the transcriptional apparatus but they do not appear to correlate with HIF-1a inhibition.
ATM/ATR-dependent signaling pathways are not required for the inhibition of HIF-1a by UVC The results presented to this point are consistent with the conclusion that inhibition of HIF-1a by UVC irradiation is independent from a DNA damage response. However, they do not formally rule out the possible involvement of a DNA damage-dependent pathway elicited by lesions generated on the sense strand of actively transcribed genes (Ljungman, 2005) . DNA damage responses are mainly mediated by ATM and ATR, members of the PI3Kinase family. In particular, ATR is primarily involved in the repair of single strand DNA breaks (Hammond and Giaccia, 2004; Shechter et al., 2004) , while ATM mediates responses in the presence of DNA double strand breaks (Kurz and Lees-Miller, 2004) . To further investigate the potential implication of signaling pathways activated by DNA damage in the inhibition of HIF-1a by UVC, we first analyzed the requirement for a functional ATR. ATR down-regulation is lethal, therefore we used an inducible system to express a kinase dead ATR (ATRkd) in SV40 transformed fibroblasts (Cliby et al., 1998) . Fibroblasts were treated with TPT (50-500 nM), UVC (20-200 J/m 2 ) or IR (10 Gy) and cultured under hypoxic conditions for 8 h. As shown in Figure 4a , fibroblasts exposed to doxycycline for 48 h (right panel) before the experiment did express ATRkd-Flag, which was not detectable in untreated fibroblasts. HIF-1a was induced by hypoxia to similar levels in the absence (left panel) or presence (right panel) of ATRkd. UVC and TPT inhibited HIF-1a protein accumulation at both concentrations in the presence or absence of ATRkd, suggesting that a functional ATR is not required for the inhibition of HIF-1a by UVC and TPT. As shown above, IR did not affect HIF-1a levels regardless of the expression of ATRkd. Interestingly, UVC and TPT induced the phosphorylation of p53 on Ser 15 and the phosphorylation of histone H2A.X (on serine 139, referred to as gH2AX, an early response to doublestrand breaks) in cells expressing a functional ATR, consistent with the induction of DNA damage. In contrast, in cells expression ATRkd p53 phosphorylation on Ser 15 was significantly reduced and phosphorylation of gH2A.X completely abolished, suggesting that phosphorylation of p53 and H2A.X in response to DNA damage stress does require a functional ATR.
We next wanted to assess the role of ATM in the inhibition of HIF-1a by UVC or TPT. ATM-wild-type or ATM-deficient cells were treated with TPT (500 nM), UVC (20 J/m 2 ) and IR (10 Gy) and then cultured under hypoxia for 8 h. As shown in Figure 4b , hypoxia weakly induced HIF-1a in these cells, in the presence or absence of ATM. UVC and TPT inhibited hypoxic induction of HIF-1a in both cell lines regardless of the presence of ATM, suggesting that a functional ATM is not required for the inhibition of HIF-1a. UVC and TPT induced the phosphorylation of p53 and gH2A.X both in the presence and absence of ATM, suggesting that ATM is not required for the activation of a DNA damagesignaling pathway in response to UVC or TPT treatment. IR did induce a DNA damage response, yet was unable to inhibit HIF-1a protein accumulation. Interestingly, IR was able to induce p21 accumulation in the presence of ATM, but not when ATM was knocked-out, confirming that ATM is involved in the DNA damage responses induced by IR.
These data demonstrate that a functional ATR, but not ATM, is required for the response to DNA damage induced by UVC and TPT, yet it is dispensable for the inhibition of HIF-1a, further dissociating DNA damagedependent signals from the inhibition of HIF-1a protein.
UVC inhibits HIF-1a in transcription coupled-repair mechanisms (TC-NER) deficient cells UVC-induced adducts on the sense strand of the DNA halt transcription, which resumes after the repair of the DNA damage (Mellon, 2005) . Mutations of nucleotide excision repair machinery (for example CS-B) cause a dysfunctional transcription coupled-repair mechanisms (TC-NER) and an inability to resume transcription after UV-induced damage (Mayne and Lehmann, 1982) . To test whether proteins involved in the TC-NER have a role in the inhibition of HIF-1a by UVC, we used human fibroblasts derived either from patients affect by Cockayne Syndrome (deficient of a functional CS-B protein) or from healthy donors. CS-B fibroblasts and normal fibroblasts were treated with TPT (500 nM) or irradiated with UVC (20-200 J/m 2 ), before being placed under hypoxia for 8 h. As shown in Figure 5a , hypoxia induced the accumulation of HIF-1a in both CS-B and normal fibroblasts. UVC and TPT inhibited HIF-1a accumulation in both cell lines. Interestingly, gH2A.X was detectable in normal fibroblasts only in response to high doses of UVC, while in CS-B fibroblasts it was also detected in response to the low dose of UVC and TPT, suggesting a more pronounced accumulation of DNA damage in these cells. Despite the increased sensitivity of CS-B cells to UVC induced DNA damage, documented by a more pronounced induction of gH2A.X in CS-B cells (Figure 5b ), HIF-1a inhibition was equally detectable in both cell lines, ruling out that a functional TC-NER might be implicated in the inhibition of HIF1a by UVC or TPT.
Inhibition of HIF-1a by UVC does not require topoisomerase I UVC irradiation can induce the formation of topoisomerase I (Top1) cleavage complexes on the DNA. Given the strong similarities in the inhibition of HIF-1a by TPT and UVC, we tested if expression of Top1 was required for the inhibition of HIF-1a by UVC irradiation. U251 cells were transfected with siRNA specific for Top1 or a negative control (NC) siRNA and then cultured under normoxic or hypoxic conditions for 8 h after being either treated with TPT (500 nM) or irradiated with UVC (20 J/m 2 ). As shown in Figure 6 , in cells transfected with a NC siRNA hypoxia induced a marked accumulation of HIF-1a that was decreased by 65% following UVC irradiation and by 90% in the presence of TPT. Notably, transfection with a Top1 specific siRNA, which effectively decreased Top1 expression, significantly blocked the ability of TPT to inhibit HIF-1a (30% inhibition compared to 90% inhibition in cells transfected with NC siRNA), but neither affected hypoxic induction of HIF-1a nor HIF1a inhibition by UVC. Similarly, siRNA targeting Topo2a had no effect either on the induction of HIF1a by hypoxia or on the inhibition by UVC and TPT (data not shown).
These results suggest that the inhibition of HIF-1a protein accumulation by UVC, unlike that effected by TPT, does not require the expression of Top1, suggesting that UVC inhibits HIF-1a by a pathway remarkably similar to the one activated by TPT, yet triggered by a distinct 'initiating' biochemical signal.
Discussion
In an effort to better understand the existence of a relationship between DNA damaging agents and inhibition of HIF-1a protein accumulation, we discovered that UVC inhibits HIF-1a translation in a dose-dependent, p53-independent fashion.
An increasing number of HIF-1 inhibitors are being described in the literature and are either in preclinical development or in early clinical trials (Rapisarda et al., 2004a; Melillo, 2006; Semenza, 2006) . Most of the HIF-1 inhibitors described act by indirect, non-selective mechanisms of action, which raises questions as to how best develop them in the clinical setting. Using a luciferase-based HTS, we have screened several libraries of small molecules, including the NCI Diversity set (Rapisarda et al., 2002) , the NCI Training set, a collection of approximately 200 compounds with a known mode of action (unpublished) and 140 000 compounds from the NCI open synthetic repository. A remarkable common feature of these screening activities has been the large representation of DNA damaging agents among the active leads, which raises concerns about their specificity and the potential for further clinical development as HIF-1 inhibitors.
A prototype HIF-1 inhibitor, which is also a potent DNA damaging agent, is TPT, a Top1 poison. We originally found that TPT, along with a number of camptothecin analogs present in the NCI libraries screened, inhibits HIF-1a protein translation by a mechanism that does not require DNA replication, but does require ongoing RNA transcription (Rapisarda et al., 2004b) . In this paper we provide evidence that UVC also inhibits HIF-1a protein translation by a remarkably similar mechanism of action. Indeed, UVC, at doses that do not affect global protein synthesis, inhibited HIF-1a translation in a proteasome-independent fashion. Further similarities with the inhibition of HIF-1a by TPT were observed in experiments conducted in the presence of aphidicolin, which demonstrated that DNA replication-mediated DNA damage was dispensable for HIF-1a inhibition, or in the presence of RNA polymerase inhibitors, which confirmed that ongoing RNA transcription was required for HIF-1a inhibition by UVC. Interestingly, RNA pol II inhibitors have been shown to paradoxically increase HIF-1a accumulation, presumably by blocking a transcription-dependent negative feedback loop that leads to HIF-1a degradation (Demidenko et al., 2005) . This finding is important also because it rules out that the inhibition of HIF-1a by UVC be dependent on inhibition of mRNA expression, consistent with lack of effect of UVC on HIF-1a mRNA expression. The striking similarities between the mechanism of inhibition of HIF-1a by UVC and TPT and the notion that UVC may implicate Top1 in the induction of DNA damage (Soe et al., 2004) , prompted us to investigate the requirements for Top1 in the inhibition of HIF-1a by UVC. As clearly demonstrated in Figure 6 , transfection of siRNA targeting Top1 almost completely blocked the ability of TPT to inhibit hypoxic induction of HIF-1a, but had no effect on UVC-mediated inhibition of HIF-1a protein. These results demonstrate that despite the striking similarities between UVC and TPT in the inhibition of HIF-1a protein, distinct 'triggering' signals activate these pathways. In fact, TPT requires the presence of a cleavage complex (Top1-DNA), while UVC does not require Top1 and might rely on the formation of CPDs and (6-4)PPs on the DNA; however, both pathways require ongoing RNA transcription to inhibit HIF-1a by a signaling pathway that remains to be fully elucidated. The intriguing finding that UVC, but not other potent DNA damaging signals, such as IR, inhibits HIF-1a protein, further separates the signaling pathways associated with DNA damage and HIF-1 inhibition. Inhibition of HIF-1a by UVC does not require Top1. U251 cells were transfected with either negative control (NC) siRNA, or siRNA targeting Top1, respectively. Cells were either subjected to normoxic condition or treated with TPT (500 nM) or UVC irradiation under hypoxic conditions for 8 h. HIF-1, hypoxia inducible factor 1; TPT, topotecan.
DNA damage-independent inhibition of HIF-1a by UVC A Rapisarda and G Melillo Inhibition of HIF-1a by signals associated with profound alterations of global metabolic pathways requires rigorous scrutiny. Data shown here demonstrate a clear dose-dependent effect of UVC in the inhibition of HIF-1a protein accumulation. Indeed, lowdoses of UVC inhibited HIF-1a translation in the absence of significant effects on global protein synthesis or the expression and function of key translational factors, such as eIF2a and eIF4E. However, translation of HIF-1a is still poorly understood and the possibility that UVC might interfere with the function of an Internal Ribosome Entry Site (IRES), which has been implicated in HIF-1a translation under hypoxic conditions (Lang et al., 2002) , remains to be further investigated. In contrast, high doses of UVC (200 J/m 2 ) clearly acted by a non-specific mechanism which was insensitive to addition of actinomycin D or other RNA polymerase inhibitors and was associated with profound inhibition of global protein synthesis and short lived proteins.
A question that had not been previously adequately addressed was the association of signaling pathways activated by DNA damage with HIF-1 inhibition. Genotoxic stress is primarily sensed by ATR and ATM, kinases belonging to the PI3K family. The signaling pathways activated by these kinases allow the cells to either repair the DNA damage and recover or undergo apoptosis, and are essential for the integrity of the genome . To address this question we have used normal human fibroblast in which ATM or ATR were genetically altered. Consistent with published work (Heffernan et al., 2002; Furuta et al., 2003) , DNA damage induced by both TPT and UVC was sensed by a functional ATR pathway, and was associated with induction of gH2A.X and p53 phosphorylation on Ser
15
. Unlike the sensing of DNA damage, which was impaired in ATR deficient cells, inhibition of HIF-1a by both TPT and UVC was preserved regardless of the ATR status. These results clearly demonstrate that an intact sensing of DNA damage is not required for HIF-1a inhibition.
DNA damage can also be potentially induced on the sense strand of actively transcribed genes, thus TC-NER are in place to repair DNA damage and preserve the integrity of the genome during this type of genotoxic stress (Tornaletti, 2005) . There are known human diseases (such as the Cockaine Syndrome) that are characterized by a hypersensitivity to UV light (Berneburg and Lehmann, 2001) . One of the hallmarks of Cockaine Syndrome cells is their inability to resume transcription after UV-induced damage (Mayne and Lehmann, 1982) , which has been commonly ascribed to the defect that these cells display in the TC-NER. Two complementation groups (A and B) have been identified among CS patients and reflect the lack of function of two distinct proteins (CS-A and CS-B) involved in TC-NER. Therefore, it was important to address whether cells deficient in TC-NER would be more sensitive to HIF-1a inhibition by UVC or TPT. It has been shown recently that CS-B is not only involved in the recruitment of NER factors, but it is also pivotal for the transcription of DNA damage induced genes after UV irradiation (Laine and Egly, 2006; Proietti-De-Santis et al., 2006) , hence we tested our hypothesis in cells from CS-B patients. Data shown in Figure 5 clearly show that while DNA damage is indeed more pronounced in CS-B cells, HIF-1a inhibition was equally achieved in wildtype or CS-B fibroblast by both TPT and UVC, demonstrating a lack of correlation between transcription-coupled DNA damage mechanisms and HIF-1 inhibition.
Results previously published and extended in this manuscript, providing compelling evidence that DNA damage is not required for or associated with inhibition of HIF-1a by UVC or TPT, have important clinical implications. Efforts are ongoing to develop HIF-1 inhibitors as antiangiogenic and anticancer agents. In particular, a clinical trial is currently ongoing at the NCI to test the ability of TPT to inhibit HIF-1a expression in patients with metastatic cancers. These studies were at least in part based on the evidence that chronic administration of TPT is effective in inhibiting HIF-1a and angiogenesis in xenograft models (Rapisarda et al., 2004c) . Induction of DNA damage and cytotoxicity by TPT requires, and is usually achieved at, doses near the MTD. In contrast, the paradigm underlying the use of TPT as HIF-1 inhibitor is based on the assumption that protracted administration of lower doses, unlikely to achieve significant DNA damage, may be advantageous to modulate the HIF-1 pathway in the absence of undesirable toxicities. Hence, our conclusion that HIF-1 inhibition is dissociated from the induction of DNA damage is essential to support further clinical development of this agent as HIF-1 inhibitor.
Materials and methods
Cell lines and reagents U251 and HCT-116 were obtained from NCI. ATM proficient (YZ3) and deficient (pEBs) cells were kindly provided by Dr Giaccia (Ziv et al., 1997; Hammond et al., 2003) . SV40-transformed fibroblasts expressing an inducible ATR kinase dead (ATRkd-Flag, 22.4.I.853 cells) were previously described (Cliby et al., 1998) . Normal human fibroblasts (AG06858) and fibroblasts from Cockayne patients (GM01098-CS-B) were kindly provided by Dr Pommier (Furuta et al., 2002) . IR treatment was performed by exposing cells to 0, 5, or 10 Gray of radiation (dose rate ¼ 7 Gy/min). UV-C (UVC) irradiation (254 nm) was performed using UV Stratalinker 1800 (Stratagene, La Jolla, CA, USA) CHX, MG132 and aphidicollin were purchased from Sigma. Actinomycin D was purchased from Calbiochem.
Doxorubicin, cisplatin and TPT were obtained from the Drug Synthesis and Chemistry Branch, DTP at NCI (see section Cell lines and reagents in Supplementary Information).
Immunoblot analysis
Monoclonal anti-HIF-1a and p21 antibody (BD-Transduction Laboratories, Lexington, KY, USA) anti-b-actin antibody (Chemicon International, Temecula, CA, USA), monoclonal anti-Flag antibody (Sigma, St Louis, MO, USA), anti c-myc antibody (Epitomics, Burlingame, CA, USA), anti-p53, total RNA Pol II and phosphorylated RNA Pol II (serine 5) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA), antibodies specific for phosphorylated p53 (serine 15), phosphorylated (serine 51) or total eIF2a, total eIF4E, total and phosphorylated H2A.X (gH2A.X, serine 139) (Cell Signaling Technology, Beverly, MA, USA) were used accordingly to manufacture's protocols. Polyclonal antibody for Top1 was a kind gift from Dr Y Pommier (see section Immunoblot analysis in Supplementary Information).
Real-time PCR VEGF and HIF-1a expression was measured by real-time PCR as described previously (Rapisarda et al., 2002) . 18S rRNA was used as an internal control (see section Real-time PCR in Supplementary Information).
HIF-1a protein translation assay U251 cells were exposed to methionine/cysteine-free RPMI 1640 for 4 h after being exposed to UVC 20-200 J/m 2 . Total cell lysates were subjected to immunoprecipitation using anti-HIF-1a antibody (Novus Biologicals, Littleton, CO, USA) and autoradiographed as previously described (Rapisarda et al., 2004b ) (see section HIF-1a protein translation assay in Supplementary Information).
siRNA transfection U251 cells were transfected with 20 nM of siRNA. Transfection was performed using Oligofectamine Reagent according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA). The siRNA used was either Top1 SMARTpool (Dharmacon, Chicago, IL, USA) or control (non-silencing) siRNA (Qiagen, Valencia, CA, USA). Following transfection cells were allowed to recover for 48 h before treatment.
